Retatrutide and Tirzepatide from ₱750 a vial in 25, 50 and 100 packs. Split it with friends or resell it under your own label.From ₱750 a vial: 25, 50 and 100 packs for group buys and resellers. See bulk prices →

Guides · Oral semaglutide

Wegovy Pill Philippines: The Oral Semaglutide Reality

Searches for a Wegovy pill price in the Philippines run into a registration gap: a Wegovy tablet has a US approval but no Philippine registration. The oral semaglutide registered here is Rybelsus. This filing untangles the naming, what the FDA Philippines register and the pharmacy chains show, and how the tablet differs from the pens.

Short answer

As of 23 September 2026, no Philippine pharmacy publishes a peso price for Rybelsus online, although it is registered with FDA Philippines (BR-1413, BR-1411, BR-1412). Rybelsus is a once-daily semaglutide tablet for type 2 diabetes. The FDA Philippines portal returned no registration for a Wegovy tablet. Rybelsus needs a prescription, and prescribing belongs with a licensed Philippine physician.

Video guide: Ozempic vs Wegovy vs Rybelsus in the Philippines (2:10)
Video transcript

Ozempic, Wegovy and Rybelsus. Three brand names in the Philippines, and one molecule inside all three: semaglutide. Ozempic is a weekly pen labelled for type 2 diabetes. Wegovy is a weekly pen labelled for weight management. Rybelsus is a daily tablet. At Watsons, Ozempic pens cost ₱8,187.50 to ₱9,280, and Wegovy pens ₱9,900 to ₱12,650. At the matched 1 mg strength, Wegovy costs about 7 percent more than Ozempic. The 1.7 mg and 2.4 mg pens exist only as Wegovy. Rybelsus is registered with FDA Philippines, yet Watsons, Southstar Drug and Rose Pharmacy list no price for it online, and Mercury Drug publishes none. And the Wegovy pill? A Wegovy tablet has a US approval, but no Philippine registration. The semaglutide tablet registered here is Rybelsus. All three are prescription medicines. Prescribing belongs with a licensed Philippine physician. A research vial of semaglutide is not the same product. The pens and tablet are registered medicines. The vial is not approved for human use and is sold for research only. Our partner and supplier, Primara Labs, lists a 15 mg semaglutide vial at ₱1,990, or ₱1,216 per vial in a 10 pack. Per mg, the Ozempic 1 mg pen holds 4 mg, about ₱2,320 each. The vial is about ₱133, or ₱81 in a 10 pack. Not the same product. Every vial order includes bacteriostatic water, insulin syringes and alcohol pads. Stock is held in Metro Manila: order by noon on a weekday for same-day delivery, or J&T to the provinces. And there is a 60-day money-back guarantee. Read the full comparison on Philippines Peptides, then see semaglutide at Primara Labs and order on WhatsApp.

Snapshot

WEGOVY TABLET IN PH
Not registered
RYBELSUS IN PH
3 registrations
RYBELSUS PH PRICE
None published
WEGOVY 2.4MG PEN
₱12,650 (Watsons)

What semaglutide is, what its trials measured and the side effects they reported are covered in the semaglutide compound guide. A research-grade semaglutide vial is not a registered medicine and not a substitute for a prescribed pen or tablet.

The Wegovy Pill Confusion

Novo Nordisk sells the same molecule, semaglutide, under three brand names registered in the Philippines. Ozempic is the weekly injectable pen that US FDA and EMA records list for type 2 diabetes. Wegovy is the weekly injectable pen those records list for weight management. Rybelsus is the once-daily tablet. In the Philippines, the semaglutide tablet on the register is Rybelsus.

Drugs@FDA lists a Wegovy tablet approval in the United States (NDA218316, approved 22 December 2025), but the FDA Philippines verification portal returned no Philippine registration for it on 23 September 2026. A Wegovy pill offered for sale in the Philippines is therefore not a registered product here.

For the injectable Wegovy pen itself, including pen-by-pen pesos, see the Wegovy price guide and the Ozempic price filing.

Rybelsus in PH Pharmacies

Rybelsus is registered with FDA Philippines as a prescription medicine in 3 mg, 7 mg and 14 mg tablets (BR-1411, BR-1412 and BR-1413), checked on 23 September 2026. It is dispensed the same way as the pens: a prescription first, and prescribing belongs with a licensed Philippine physician.

On price, there is nothing verified to publish. When the chains were checked on 23 September 2026, Mercury Drug, Watsons, Southstar Drug and Rose Pharmacy published no peso price for Rybelsus online. So no mainstream pharmacy publishes a figure, and a quoted price is a reseller or import figure rather than a pharmacy listing. This page will not invent a range to fill that gap.

For the pen route, which does have published figures: a Wegovy 2.4 mg pen is ₱12,650 at Watsons and an Ozempic 1 mg pen is ₱9,280 at Watsons, checked 23 September 2026.

Tablet vs Pen

FactorRybelsus (tablet)Ozempic / Wegovy (pen)
ScheduleOnce dailyOnce weekly
NeedlesNoneSubcutaneous injection
Strengths in PH3 mg, 7 mg and 14 mgOzempic 0.25 mg, 0.5 mg and 1 mg; Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg
Published PH priceNone publishedListed by MedsGo, MedsGo on Lazada, PULSE Clinic, Rose Pharmacy, Southstar Drug and Watsons
PrescriptionRequiredRequired

The tablet removes the injection and adds rules about how it is taken, which are set out in the Rybelsus prescribing information. Which form suits a given person is a decision for the prescriber, and prescribing belongs with a licensed Philippine physician.

What About Compounded Semaglutide?

Compounded semaglutide is a United States term. Per the US FDA's statement on unapproved GLP-1 drugs, licensed US compounding pharmacies produced semaglutide while it was on the FDA drug shortage list, and the agency has since declared that shortage resolved.

Under RA 9711 a drug must be registered with FDA Philippines before it is imported, sold or distributed; the detail is in the regulation hub. Manila Bulletin reported on 14 March 2026 that a doctors' group warned the public against compounded, non-FDA-registered versions of Ozempic and Mounjaro. The molecule itself is covered in the semaglutide guide.

FAQ

Is there a Wegovy pill in the Philippines?

Not a registered one. Drugs@FDA lists a Wegovy tablet approval in the United States (NDA218316, approved 22 December 2025), but the FDA Philippines verification portal returned no Philippine registration for it on 23 September 2026. The oral semaglutide registered in the Philippines is Rybelsus (BR-1411, BR-1412 and BR-1413), a once-daily tablet from Novo Nordisk that needs a prescription, and prescribing belongs with a licensed Philippine physician.

How much does the Wegovy pill or oral semaglutide cost in the Philippines?

No Philippine pharmacy publishes one. On 23 September 2026, Mercury Drug, Watsons, Southstar Drug and Rose Pharmacy published no peso price for Rybelsus online, and no Wegovy tablet is registered here. A Rybelsus price quoted online is a reseller or import figure, not a pharmacy listing. The injectable pens do have published figures: Wegovy 2.4 mg is PHP 12,650 a pen at Watsons and Ozempic 1 mg is PHP 9,280.

Is Rybelsus available at Mercury Drug, and what is the price?

Mercury Drug publishes no medicine prices online, so its Rybelsus price and branch stock can be confirmed only by phone or at the counter. No other mainstream Philippine chain published a Rybelsus peso figure when checked on 23 September 2026. Rybelsus is a prescription medicine.

Is there an Ozempic tablet?

Not in the Philippines. The FDA Philippines register lists Ozempic only as injectable pens (4 certificates), and the semaglutide tablet registered here is Rybelsus. In the United States, Drugs@FDA lists the semaglutide tablet application NDA213051 under the names Rybelsus and Ozempic (tablets). An Ozempic tablet offered in the Philippines is not a registered product here.

Can compounded semaglutide be bought in the Philippines?

Not as a registered medicine. Under RA 9711 a drug must be registered with FDA Philippines before it is imported, sold or distributed, and the registered semaglutide products here are Ozempic, Wegovy and Rybelsus. Manila Bulletin reported on 14 March 2026 that a doctors' group warned the public against compounded, non-FDA-registered versions of Ozempic and Mounjaro.

Sources

  1. [01]LabelRybelsus Prescribing Information

    Novo Nordisk. Rybelsus (oral semaglutide) full prescribing information, including administration requirements.

    https://www.novo-pi.com/rybelsus.pdf
  2. [02]ReferenceUS FDA · Drugs@FDA, semaglutide

    US approval records for Ozempic, Wegovy and the semaglutide tablets, read 23 September 2026.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637
  3. [03]ReferenceFDA Philippines · Drug Verification Portal

    FDA Philippines verification portal for registered prescription medications, searched 23 September 2026.

    https://verification.fda.gov.ph/
  4. [04]ReferenceUS FDA · Compounded GLP-1 Statement

    US FDA statement on compounded semaglutide and the resolution of the semaglutide shortage.

    https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  5. [05]NewsManila Bulletin, 14 March 2026

    Doctors' group warns public vs compounded, non-FDA registered versions of Ozempic, Mounjaro

    https://mb.com.ph/2026/03/14/doctors-group-warns-public-vs-compounded-non-fda-registered-versions-of-ozempic-mounjaro

Updated